1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. DAY ONE BIOPHARMACEUTICALS INC
Day One Biopharmaceuticals Inc XNAS: DAWN
21.25 -0.03 (-0.14%)
5.3M

XNAS 11 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Analyst Downgrade
H.C. Wainwright downgrades Day One Biopharmaceuticals to 'Neutral' on acquisition deal by Servier See details

Day One Biopharma Inc - DAWN - stock price prediction, stock price target, analyst ratings from 8 analysts

Day One Biopharma Inc has a share price target of US$ 22, revenue growth forecast of 52.4%, and profit growth estimate of 24.7% for FY26, based on top 8 analyst calls.